Drug Profile
ACH 04
Alternative Names: ACH04Latest Information Update: 16 Oct 2021
Price :
$50
*
At a glance
- Originator Ache Laboratories
- Class Antidiarrhoeals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diarrhoea
Most Recent Events
- 14 Oct 2021 Discontinued - Phase-II for Diarrhoea in Brazil (unspecified route) (Ache Laboratories pipeline, October 2021)
- 31 Dec 2014 Phase-II clinical trials in Diarrhoea in Brazil (unspecified route) prior to December (Ache Laboratories annual report,